EXPERIENCE YOU CAN TRUST
The firm specializes in complex, commercial litigation. The firm's principal, Joshua H. Grabar, has been involved in some of the largest class actions of the last two decades.
DEDICATION YOU CAN RELY ON
We take pride in providing effective and aggressive representation. Our reputation and history of success speaks for itself and drives lasting client relationships. We are here for you.
LET'S WORK TOGETHER
If you have suffered a financial loss as a result of securities fraud, price-fixing or consumer fraud, you can rest assured that we are on your side. If you are a business seeking to avoid unnecessary legal liability, or reduce the costs of compliance, we are your solution.
latest blog
Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical trial of one of the company’s lead immunotherapy candidates. In a complaint in Boston federal court Tuesday, Replimune investor John Chea claimed the company’s CEO Sushil Patel, Chief Financial Officer Emily Hill, board Chair Philip…
Read More 
Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical trial of one of the company’s lead immunotherapy candidates. In a complaint in Boston federal court Tuesday, Replimune investor John Chea claimed the company’s CEO Sushil Patel, Chief Financial Officer Emily Hill, board Chair Philip…
Read More 
Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania
By Grabar Law |
Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United States District Court for the District of New Jersey, alleging a price-fixing conspiracy dating back to 2011 involving pharmaceutical manufacturers, insurance companies, and their affiliated pharmacy benefit managers (PBMs) to artificially inflate the prices of…
Read More 
Grabar Law Office In the News: Â Geron Shareholder Sues Execs Over Drug Launch Claims
By Grabar Law |
A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company’s top brass, accusing them of making misleading statements about the commercial prospects of its cancer drug despite knowing that the company faced challenges to the drug’s success. The complaint filed againstseveral current and former executives and…
Read More